Mr. SEKAR, age 60, had a fasting plasma glucose level of 194 mg/dL, above the normal range of 70-100 mg/dL and in the prediabetes range of 100-125 mg/dL. His HbA1c level was 8.5%, above the diabetic range of 6.5% or higher. His calculated mean blood glucose was 197 mg/dL. The test results indicate the patient has diabetes based on his HbA1c and fasting plasma glucose levels being above the cut-off points for diabetes. The report recommends HbA1c for monitoring diabetic control and discusses target HbA1c ranges for excellent, fair, unsatisfactory and poor control.
Mr. SEKAR, age 60, had a fasting plasma glucose level of 194 mg/dL, above the normal range of 70-100 mg/dL and in the prediabetes range of 100-125 mg/dL. His HbA1c level was 8.5%, above the diabetic range of 6.5% or higher. His calculated mean blood glucose was 197 mg/dL. The test results indicate the patient has diabetes based on his HbA1c and fasting plasma glucose levels being above the cut-off points for diabetes. The report recommends HbA1c for monitoring diabetic control and discusses target HbA1c ranges for excellent, fair, unsatisfactory and poor control.
Mr. SEKAR, age 60, had a fasting plasma glucose level of 194 mg/dL, above the normal range of 70-100 mg/dL and in the prediabetes range of 100-125 mg/dL. His HbA1c level was 8.5%, above the diabetic range of 6.5% or higher. His calculated mean blood glucose was 197 mg/dL. The test results indicate the patient has diabetes based on his HbA1c and fasting plasma glucose levels being above the cut-off points for diabetes. The report recommends HbA1c for monitoring diabetic control and discusses target HbA1c ranges for excellent, fair, unsatisfactory and poor control.
Mr. SEKAR, age 60, had a fasting plasma glucose level of 194 mg/dL, above the normal range of 70-100 mg/dL and in the prediabetes range of 100-125 mg/dL. His HbA1c level was 8.5%, above the diabetic range of 6.5% or higher. His calculated mean blood glucose was 197 mg/dL. The test results indicate the patient has diabetes based on his HbA1c and fasting plasma glucose levels being above the cut-off points for diabetes. The report recommends HbA1c for monitoring diabetic control and discusses target HbA1c ranges for excellent, fair, unsatisfactory and poor control.
1. HbA1c is used for monitoring diabetic control. It reflects the Mean blood glucose . 2. HbA1c has been endorsed by clinical groups & ADA (American Diabetes Association) guidelines 2017, for diagnosis of diabetes using a cut-off point of 6.5%. 3. Interference of Haemoglobinopathies in HbA1c estimation. A. For HbF > 25%, an alternate platform (Fructosamine) is recommended for testing of HbA1c. B. Homozygous hemoglobinopathy is detected, fructosamine is recommended for monitoring diabetic status C. Heterozygous state detected (D10/ turbo is corrected for HbS and HbC trait). 7. In known diabetic patients, following values can be considered as a tool for monitoring the glycemic control. Excellent Control - 6 to 7 %, Fair to Good Control - 7 to 8 %, Unsatisfactory Control - 8 to 10 % and Poor Control - More than 10 % .
Discussed With
Dr. VINOD KUMAR PANICKER Dr.C.Vimala, M.D., (PATH)